<DOC>
	<DOCNO>NCT00196638</DOCNO>
	<brief_summary>Treatment acute primary HIV infection may improve long-term outcome . However , optimal treatment still debate . The ANRS 112-INTERPRIM trial evaluates three different therapeutical strategy , combine permanent intermittent HAART cytokine , interferon alpha , order determine combination allow best control HIV viremia 24 week antiretroviral treatment interruption</brief_summary>
	<brief_title>Multicentric Trial Comparing Three Therapeutical Strategies Patients With Acute Primary HIV Infection</brief_title>
	<detailed_description>Treatment acute primary HIV infection may improve long-term outcome . However , optimal treatment still debate . The main objective multicentric randomize phase II/III study compare HIV viremia 92 96 week acute primary HIV infection , patient treat 3 different strategy . In first group , patient receive antiretroviral drug ( HAART ) continuously week 72 . In second group , patient receive HAART continuously week 36 , intermittently week 72 . In third group , patient receive HAART group II , pegylated interferon alpha administer initial 14 week , 3 week 3 HAART interruption week 36 week 72 . All patient monitor without HAART week 96 . Enrolled patient circulate p24 antigen and/or HIV viremia , uncompleted HIV western blot , 18 65 year old , agree participate study . They receive antiretroviral drug , pregnant , without neuro-psychological autoimmune disorder , without chronic hepatitis . Secondary objective study : quality immune restoration , anti-HIV immune response , safety adhesion treatment . A total 90 patient ( 30 group ) enrol .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>P24 antigen positive neutralization positive plasma HIV RNA Negative complete Western Blot With symptom Written inform consent Previous antiretroviral treatment Pregnancy Biological abnormality Hepatitis C B</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>Primary acute infection</keyword>
	<keyword>Interferon-alpha</keyword>
</DOC>